This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2023.
Company Filing History:
1 out of 1,266 
1 out of 483 
Years Active: 2023
Title: The Innovative Contributions of Robert Hilgraf
Introduction
Robert Hilgraf is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work focuses on creating methods that can effectively treat or prevent various types of cancers.
Latest Patents
Robert Hilgraf holds 1 patent for his invention titled "Compounds and methods useful for treating or preventing cancers." This patent includes CSNK1A1 inhibitors that are particularly useful in treating or preventing cancers such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and colon cancer. His research aims to provide new avenues for cancer therapy, addressing critical medical needs.
Career Highlights
Throughout his career, Robert has worked with prestigious organizations, including the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. These institutions are renowned for their contributions to cancer research and treatment, providing a solid foundation for his innovative work.
Collaborations
Robert has collaborated with esteemed colleagues such as Steven M. Corsello and Todd R. Golub. Their combined expertise has likely enhanced the impact of his research and the development of effective cancer treatments.
Conclusion
Robert Hilgraf's contributions to cancer research through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in the field of oncology.